Combined introduction of anti-IL2 receptor antibodies, mycophenolic acid and tacrolimus: effect on malignancies after renal transplantation in a single-centre retrospective cohort study.
暂无分享,去创建一个
D. Abramowicz | K. Wissing | V. del Marmol | A. Massart | A. Le Moine | J. Racapé | L. Ghisdal | A. Lemy | N. Broeders | P. Braconnier | P. Madhoun | Mireille N. Kianda
[1] D. Lott,et al. Aggressive Behavior of Nonmelanotic Skin Cancers in Solid Organ Transplant Recipients , 2010, Transplantation.
[2] R. Kaufmann,et al. Switch to a Sirolimus‐Based Immunosuppression in Long‐Term Renal Transplant Recipients: Reduced Rate of (Pre‐)Malignancies and Nonmelanoma Skin Cancer in a Prospective, Randomized, Assessor‐Blinded, Controlled Clinical Trial , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[3] L. Naldi,et al. Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study. , 2010, Archives of dermatology.
[4] J. Campistol. Minimizing the Risk of Posttransplant Malignancy , 2009, Transplantation.
[5] F. Schena,et al. Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial , 2009, Transplantation.
[6] C. Decaestecker,et al. Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[7] Aaron Dall,et al. BK virus nephritis after renal transplantation. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[8] P. Vereerstraeten,et al. HLA Mismatches Remain Risk Factors for Acute Kidney Allograft Rejection in Patients Receiving Quadruple Immunosuppression With Anti-Interleukin-2 Receptor Antibodies , 2008, Transplantation.
[9] P. Halloran,et al. Reduced exposure to calcineurin inhibitors in renal transplantation. , 2007, The New England journal of medicine.
[10] O. Stoeltzing,et al. Mycophenolate Mofetil Inhibits Tumor Growth and Angiogenesis In Vitro but Has Variable Antitumor Effects In Vivo, Possibly Related to Bioavailability , 2007, Transplantation.
[11] J. Kaldor,et al. Cancer incidence before and after kidney transplantation. , 2006, JAMA.
[12] D. Hanto,et al. Post‐transplant de novo malignancies in renal transplant recipients: the past and present , 2006, Transplant international : official journal of the European Society for Organ Transplantation.
[13] G. Opelz,et al. Disassociation Between Risk of Graft Loss and Risk of Non-Hodgkin Lymphoma With Induction Agents in Renal Transplant Recipients , 2006, Transplantation.
[14] E. Decullier,et al. Subsequent Skin Cancers in Kidney and Heart Transplant Recipients after the First Squamous Cell Carcinoma , 2006, Transplantation.
[15] S. Sacks,et al. Prospective Registry‐Based Observational Cohort Study of the Long‐Term Risk of Malignancies in Renal Transplant Patients Treated with Mycophenolate Mofetil , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[16] P. Karran,et al. Azathioprine and UVA Light Generate Mutagenic Oxidative DNA Damage , 2005, Science.
[17] A. Webster,et al. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data , 2005, BMJ : British Medical Journal.
[18] E. Geissler,et al. PRO- AND ANTI-CANCER EFFECTS OF IMMUNOSUPPRESSIVE AGENTS USED IN ORGAN TRANSPLANTATION , 2004, Transplantation.
[19] B. Kasiske,et al. Cancer after Kidney Transplantation in the United States , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[20] G. Opelz,et al. Lymphomas After Solid Organ Transplantation: A Collaborative Transplant Study Report , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[21] E. Taioli,et al. Incidence of cancer after kidney transplant: results from the North Italy transplant program , 2003, Transplantation.
[22] L. Swinnen,et al. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation1 , 2003, Transplantation.
[23] R. Loertscher,et al. Malignancy after renal transplantation: Incidence and role of type of immunosuppression , 2002, Annals of Surgical Oncology.
[24] G Flandrin,et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[25] A. Sheil. Patterns of malignancies following renal transplantation. , 1999, Transplantation proceedings.
[26] T. Mathew. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. , 1998, Transplantation.
[27] T. Mathew. A Blinded, Long-term, Randomized Multicenter Study Of Mycophenolate Mofetil In Cadaveric Renal Transplantation: Results at Three Years1,2 , 1998 .
[28] B. Dréno,et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens , 1998, The Lancet.
[29] P. Kennedy,et al. Squamous cell carcinoma of the skin of the trunk and limbs: the incidence of metastases and their outcome. , 1992, The Australian and New Zealand journal of surgery.
[30] K. Lynn,et al. First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[31] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[32] C. Balch,et al. AJCC Cancer Staging Manual. 6th ed , 2002 .
[33] Clara D. Bloomfield,et al. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997. , 2000, The hematology journal : the official journal of the European Haematology Association.
[34] EINZ,et al. UROTHELIAL CARCINOMA ASSOCIATED WITH THE USE OF A CHINESE HERB ( ARISTOLOCHIA FANGCHI ) , 2022 .